3rd Annual Atlanta Precision Oncology Symposium

 

3rd Annual Atlanta Precision Oncology Symposium
E

EGFR+ Advanced NSCLC: Should 1L Therapy Include an EGFR Inhibitor Regardless of PD-L1 Expression?

By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Edward Garon
By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Edward Garon
99 views
February 9, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

18:56
Incyte

The Importance of NGS Testing in iCCA – A Patient Case

Feat. M. Khasawneh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Videos
12:36

Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

542 views
26:48

Targeted Therapies for Advanced Urothelial Cancer: Erdafitinib for P…

3rd Annual Atlanta Precision Oncology Symposium

D. Petrylak

148 views
13:52

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

38 views
25:48

2021 Expert Discussion on GU Cancers: Should We Use Olaparib Before …

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis, D. Petrylak, T. Zhang

239 views
26:48

Treatment of DNA Repair-Deficient Advanced Prostate Cancer

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis

244 views
26:42

2021 Expert Discussion on Advanced NSCLC: Is Osimertinib a Good Sequ…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon, N. Hanna, H. Borghaei, J. Kirkpatrick

393 views
23:13

Early Detection of Lung Cancer: Molecular Enrichment Strategy

3rd Annual Atlanta Precision Oncology Symposium

J. Kirkpatrick

101 views
18:36

Selecting Systemic First-Line Treatment in Stage IV NSCLC Without Dr…

3rd Annual Atlanta Precision Oncology Symposium

N. Hanna

327 views
20:20

2021 Expert Discussion on BC: How to Preoperatively Manage TNBC? How…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer, J. Litton, R. O’Regan

38 views
32:45

2021 Updates on Systemic Therapy for TNBC: Why Should We Choose Neoa…

3rd Annual Atlanta Precision Oncology Symposium

R. O’Regan

50 views
06:49

IO for mTNBC: Overview of the Efficacy Data

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

352 views
13:30

ADCs & Targeted Therapies for Advanced TNBC: Can Sacituzumab Govitec…

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

97 views
09:52

EGFR+ Advanced NSCLC: Should 1L Therapy Include an EGFR Inhibitor Re…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

99 views
15:01

EGFR+ Advanced NSCLC: Efficacy Data of TKIs in Combination vs. Alone…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

141 views
05:55

Sequence Algorithm for HER2+ Breast Cancer: Does Neratinib + Cape Ha…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

31 views
05:03

CNS Metastases in HER2+ MBC: PFS Data on the Addition of Tucatinib t…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

605 views
17:47

HER2+ MBC Sequencing Algorithm: Surveying the Data for Antibody-Drug…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

37 views
14:04
3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Surveying Efficacy Data for I…

Feat. T. Zhang
17:05
3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Assessing IMDC Risk Criteria …

Feat. T. Zhang
08:45

Targeting Genetic Mutations in mNSCLC: Clinical Data Overview of RET…

3rd Annual Atlanta Precision Oncology Symposium

H. Dilks

284 views